A Multicenter Retrospective Study Evaluating IL-5-Targeted Biologic Therapies for the Treatment of Asthma and Allergic Bronchopulmonary Aspergillosis in Adults With Cystic FibrosisTake-Home Points

Background: Biologic therapies targeting T-helper cell type 2 (Th2) eosinophilic inflammation have been used for difficult-to-treat asthma and allergic bronchopulmonary aspergillosis (ABPA), but safety and efficacy data are limited in the cystic fibrosis (CF) population. Research Question: Are Th2 b...

Cijeli opis

Bibliografski detalji

Glavni autori:	Sameer Desai, PhD, Sophia Shen, MD, Zosia Gryz, BSc, Elizabeth Tullis, MD, Anne L. Stephenson, MD, PhD, Bradley S. Quon, MD, MSc
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-06-01
Serija:	CHEST Pulmonary
Teme:	allergic bronchopulmonary aspergillosis asthma benralizumab cystic fibrosis mepolizumab ABPA, Th2
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2949789225000303
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!